Prehabilitation program for pancreatic cancer patients before surgery
Trimodal Prehabilitation in Pancreatic Cancer Patients Candidate to Neoadjuvant Treatment: A Pilot Study
This study is testing a program that combines exercise, nutrition, and mental support to see if it helps pancreatic cancer patients get stronger and healthier before their surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 10 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Puerta de Hierro University Hospital Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Majadahonda, Madrid) |
| Trial ID | NCT05722223 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of a trimodal prehabilitation program, which includes physical exercise, nutritional support, and psychological assistance, on pancreatic cancer patients undergoing neoadjuvant treatment. The aim is to enhance patients' physical condition prior to surgery, potentially leading to improved surgical outcomes and survival rates. The study will measure feasibility through attendance at training sessions and improvements in physical fitness, body composition, quality of life, and fatigue levels. By focusing on patients at the time of diagnosis, the program seeks to leverage a 'teachable moment' for lifestyle changes.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old with stages I-III pancreatic cancer who can complete a mile-time test and have an ECOG performance status of 0-2.
Not a fit: Patients with metastatic cancer will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve surgical outcomes and survival rates for pancreatic cancer patients.
How similar studies have performed: Other studies have shown promising results with multimodal prehabilitation approaches in various cancer types, suggesting potential success for this novel application in pancreatic cancer.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * More than 18 years old * ECOG 0-2 * Being able to complete the mile-time test * Stages I-III * Being able to understand the informed consent * Pancreatic cancer diagnosed Exclusion Criteria: * Metastasic cancer
Where this trial is running
Majadahonda, Madrid
- Hospital Universitario Puerta de Hierro Majadahonda — Majadahonda, Madrid, Spain (Recruiting)
Study contacts
- Principal investigator: Ana Ruiz-Casado, MD — HU Puerta de Hierro Majadahonda
- Study coordinator: Ana Ruiz-Casado, MD
- Email: arcasado@salud.madrid.org
- Phone: 607890187
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.